Blood Test Detects 50+ Cancers: The Future of Cancer Screening

In 2024, approximately 2 million new cancer cases are expected in the United States, with 78% of cancer deaths linked to cancers without routine screening. Join Dr. Charles Vega, Clinical Professor of Family Medicine at UC Irvine, as he explores the science behind multicancer early detection (MCED) tests, a groundbreaking blood-based technology designed to detect multiple cancers in a single test.

Learn how MCED testing addresses gaps in cancer screening, improves early detection, and has the potential to save lives.

#MCED #CancerScreening #OncologyInnovation #EarlyDetection #CancerCare #BloodBasedTesting #OncologyEducation #PatientOutcomes #CMEActivity #HealthcareAdvances